Variants other than aspartic acid at codon 69 of the human immunodeficiency virus type 1 reverse transcriptase gene affect susceptibility to nucleoside analogs

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 8, 2001, Pages 2276-2279

  Winters, M A ^a   Merigan, T C ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ASPARTIC ACID; DIDANOSINE; LAMIVUDINE; NUCLEOSIDE ANALOG; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CODON; CONTROLLED STUDY; DATA BASE; DRUG SENSITIVITY; GENE CONSTRUCT; GENE MUTATION; GENE SEQUENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; VIRUS GENE; VIRUS RESISTANCE;

CODON; DRUG RESISTANCE, MICROBIAL; GENOTYPE; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MUTATION; REVERSE TRANSCRIPTASE INHIBITORS; VARIATION (GENETICS);

EID: 0034913593     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.8.2276-2279.2001     Document Type: Article

References (21)

1. Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′-deoxythymidine (AZT): Increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase
2. A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy
3. Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects
4. Analysis of amino insertion mutations in the fingers subdomain of HIV-1 reverse transcriptase
5. Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA Panel
6. The relation between baseline HIV drug resistance and response to antiretroviral therapy: Re-analysis of retrospective and prospective studies using a standardized data analysis plan
7. Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs
8. Drug-resistance genotyping in HIV-1 therapy: The VIRADAPT randomised controlled trial
9. Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2′,3′-dideoxycytidine
10. Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an International AIDS Society-USA Panel
11. Human immunodeficiency virus reverse transcriptase and protease sequence database: An expanded data model integrating natural language text and sequence analysis programs
12. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)
13. Quantitative prediction of HIV-1 phenotypic drug resistance from genotypes: The virtual phenotype
14. A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance
15. Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy
16. Phenotypic testing predicts virological response in successive protease inhibitor-based regimens
17. Mutations in retroviral genes associated with drug resistance: 2000-2001 Update
18. Proviral and plasma virus genotyping using a line probe assay in nucleoside-treated HIV infected Veterans Affairs (VA) patients
19. Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase
20. Locations of anti-AIDS drug binding sites and resistance mutations in the three dimensional structure of HIV-1 RT
21. A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors